Prothena to Present New Data from Alzheimer's Disease Progra

DUBLIN--(BUSINESS WIRE)--$PRTA #AAIC2023--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced participation in the Alzheimer’s Association International Conference® 2023 (A...

Related Keywords

Netherlands , Amsterdam , Noord Holland , Ferenc Mart , Michael Bachner , Brian Campbell , Mark Johnson , International Conference On Alzheimer , Corporate Communications , Company On Twitter Prothenacorp , Head Of Neurodegeneration Clinical Development , Exchange Commission , Prothena Corporation , Alzheimer Association International Conference , Nasdaq , Association International , Potential Treatment , Neurodegeneration Clinical Development , Translational Medicine , What Progress , People Living , Quarterly Report , Investor Contact , Senior Director , Vice President , Investor Relations ,